HomeFileStructural heart disease

Structural heart disease

New Valvular Heart Disease Guidelines with Key TAVI and Mitral Regurgitation Updates

Valvular heart disease management guidelines were updated last week by the AHA and the ACC.  The last complete...

Risk of Coronary Obstruction in Repeat TAVR

As we gradually consolidate the information on the duration of transcatheter aortic valve replacement (TAVR) the focus...

Transfusion in TAVR: Caution Is Best

Periprocedural red blood cell transfusion in transcatheter aortic valve replacement (TAVR) correlates with increased mortality and acute...

ProGlide vs. Prostar XL to Close Post-TAVR Access

Minimalist transcatheter aortic valve replacement (TAVR) is a strategy that is here to stay. We have previously published...

The Most Read Articles in Structural Heart Disease of 2020

In this selection, we summarize for you the most important scientific news of 2020 in the field...

NT-proBNP Level Predicts Who May Benefit From TAVR

A normal or (on the other end) a very high level of NT-proBNP should make us look...

Sapien 3 Performs Well in “Jobs” for Which It Is Not Designed

Using Sapien 3, transcatheter mitral valve replacement to treat failed bioprosthetic valves can be performed with a high...

Boston Scientific Discontinues Lotus Valve and Makes a New Bet

Mechanically-expanding valve Lotus Edge was discontinued worldwide, as recently informed by its manufacturer, Boston Scientific. This is a...